CLINICAL_TRIALS
trial_result
· 2013-12-09
Clinical Trial Update: Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma [Phase 2]
Summary
Phase 2 results from a study of carfilzomib in relapsed and refractory multiple myeloma have been posted. The trial (NCT00511238) is completed with results post…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-09